Adaptive Biotechnologies Corporation ( ADPT) - Key Metrics
ADPT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.52 | $0.02 | $0.06 | $0.05 |
| 2026Q2 | $0.45 | -$0.25 | -$0.04 | -$0.05 |
| 2026Q1 | $0.46 | -$0.13 | -$0.06 | -$0.07 |
| 2025Q4 | $0.47 | -$0.09 | $0.01 | $0.01 |
| 2025Q3 | $0.62 | $0.06 | -$0.05 | -$0.05 |
ADPT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | 361.25 |
| 2026Q2 | 0% | -21.45 |
| 2026Q1 | 0% | -26.69 |
| 2025Q4 | 0% | -45.11 |
| 2025Q3 | 0% | 59.74 |
ADPT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 0.17% | 0% |
| 2026Q2 | -0.22% | 0% |
| 2026Q1 | -0.48% | 0% |
| 2025Q4 | 0.06% | 0% |
| 2025Q3 | -0.33% | 0% |
ADPT
Price: $29.24
52 week price:
Earnings Per Share: -0.45 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.2 million
Market Capitalization: 4.8 billion